Search

everythinglearnresearchcommunity

for

Search:↓

DPP may help hair regrowth by improving blood vessel function under stress.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The skin and thymus develop similarly to protect and support immunity.

Finasteride can cause a unique skin reaction on the penile shaft.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Male hormones worsen kidney transplant damage, but blocking them helps.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata involves immune response and gene changes affecting hair loss.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.